X-Chromosome Dosage Governs Enterohepatic Bile Acid Signaling to Modulate Systemic Inflammaging and Cognitive Resilience

Core Idea

The longevity advantage of XX individuals stems not only from brain‑protective escapees like KDM6A but also from X‑linked regulation of intestinal bile acid transport. Mosaic expression of X‑linked genes such as Sgk1 (which modulates ASBT) creates a heterogeneous ileal environment that buffers fluctuations in bile acid reabsorption, hepatic FXR signaling, and gut‑derived immunomodulatory metabolites. In XY individuals, uniform hemizygous expression leads to a less adaptable enterohepatic circuit, predisposing to chronic low‑grade inflammation and accelerated cognitive decline with age.

Mechanistic Model

1. X‑linked escapees set intestinal transport tone – Sgk1 escapes inactivation in a subset of intestinal epithelial cells, producing variable phosphorylation and activity of the apical sodium‑dependent bile acid transporter (ASBT). This yields a mosaic of high‑ and low‑absorptive crypts.
2. Mosaicism buffers bile acid pool dynamics – Crypts with low ASBT activity retain more primary bile acids in the lumen, favoring microbial conversion to anti‑inflammatory secondary bile acids (e.g., ursodeoxycholic acid). High‑ASBT crypts increase hepatic return, activating FXR‑dependent fibroblast growth factor‑19 (FGF19) synthesis, which suppresses hepatic CYP7A1 and limits bile acid synthesis.
3. Systemic impact on inflammaging – A balanced bile acid pool maintains intestinal barrier integrity and promotes tolerogenic dendritic cell priming, reducing circulating endotoxin and IL‑6 levels. In XY mice, uniformly high ASBT drives excess hepatic bile acid return, FXR over‑activation, and a shift toward pro‑inflammatory bile acid species that aggravate microglial activation via the TLR4‑NF‑κB axis.
4. Cognitive resilience link – Reduced systemic inflammation preserves hippocampal neurogenesis and attenuates amyloid‑β‑induced synaptic loss. Boosting KDM6A in males improves cognition, but only when coupled with normal Sgk1‑mediated bile acid homeostasis; uncoupling the two diminishes the benefit.

Testable Predictions

• Prediction 1: Intestinal‑specific Sgk1 overexpression in XY mice will increase mosaic ASBT activity, shift the bile acid pool toward more secondary acids, lower plasma IL‑6/TNF‑α, and improve performance in the Morris water maze to levels comparable to XX littermates.
• Prediction 2: XY mice with intestinal‑specific Sgk1 knockout will show uniform high ASBT, elevated primary bile acids, heightened hepatic FXR/FGF19 signaling, increased serum endotoxin, and exacerbated age‑dependent memory decline.
• Prediction 3: XX mice engineered to have skewed X‑inactivation (e.g., via Xist deletion in intestinal epithelium) will lose the protective bile acid mosaic and exhibit XY‑like inflammaging and cognitive trajectories, despite retaining two X chromosomes.

Experimental Approach

1. Generate villin‑Cre‑driven Sgk1‑overexpression and Sgk1‑KO lines on XY and XX backgrounds.
2. At 3, 12, and 24 months, quantify:
   • ileal ASBT activity (radiolabeled taurocholate uptake)
   • single‑cell RNA‑seq of intestinal epithelium to assess mosaicism of Sgk1 and other X‑linked escapees
   • fecal and serum bile acid profiles (LC‑MS)
   • plasma cytokines (IL‑6, TNF‑α, IL‑1β)
   • hepatic FXR target expression (Shp, Fgf15)
   • microglial activation state (Iba1, CD68 immunohistochemistry)
   • cognitive performance (novel object recognition, spatial learning)
3. Rescue experiments: administer FXR antagonist or supplement with ursodeoxycholic acid to test whether normalizing bile acid signaling reverses phenotypes.

Potential Confounds and Controls

• Control for gonadal hormone effects by performing gonadectomies and hormone replacement in subsets.
• Verify that observed changes are not secondary to alterations in gut microbiota composition via 16S rRNA sequencing; include antibiotic‑treated cohorts to isolate host‑genetic effects.
• Ensure that Cre expression does not itself affect intestinal physiology by using Cre‑only controls.

References

• KDM6A escapes X‑inactivation and protects brain cells
• Studies of women’s longevity offer clues to cognitive resilience
• Approximately 17% of X‑linked genes escape inactivation
• Age‑related increases in intestinal bile acid absorption driven by glucocorticoid‑mediated upregulation of ileal Sgk1
• Balanced X‑chromosome inactivation skewing in centenarians correlates with longer lifespan

This hypothesis directly links X‑chromosome dosage to intestinal bile acid handling, offering a mechanistic bridge between sex‑chromosome genetics, metabolic signaling, and neuroimmune aging that can be falsified with the outlined genetic and physiological manipulations.